<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/nano10040616</dc:identifier><dc:language>eng</dc:language><dc:creator>Gámez, Enrique</dc:creator><dc:creator>Elizondo-Castillo, Hellen</dc:creator><dc:creator>Tascon, Jorge</dc:creator><dc:creator>García-Salinas, Sara</dc:creator><dc:creator>Navascues, Nuria</dc:creator><dc:creator>Mendoza, Gracia</dc:creator><dc:creator>Arruebo, Manuel</dc:creator><dc:creator>Irusta, Silvia</dc:creator><dc:title>Antibacterial effect of thymol loaded SBA-15 nanorods incorporated in PCL electrospun fibers</dc:title><dc:identifier>ART-2020-117828</dc:identifier><dc:description>For the effective management of infected chronic wounds, the incorporation of antimicrobial drugs into wound dressings can increase their local availability at the infection site. Mesoporous silicon dioxide SBA-15 is an excellent drug carrier with tunable drug release kinetics. In this work, synthesized SBA-15 loaded with the natural antimicrobial compound thymol (THY) was incorporated into polycaprolactone (PCL) electrospun nanofibers to obtain an advanced wound dressing. Rod-shaped particles with internal parallel channels oriented along the longitudinal axis (diameter: 138 ± 30 nm, length: 563 ± 100 nm) were loaded with 70.8 wt.% of THY. Fiber mats were prepared using these particles as nanofillers within polycaprolactone (PCL) electrospun fibers. The resulting mats contained 5.6 wt.% of THY and more than half of this loading was released in the first 7 h. This release would prevent an initial bacterial colonization and also inhibit or eliminate bacterial growth as in vitro shown against Staphylococcus aureus ATCC 25923. Minimal inhibitory concentration (MIC: 0.07 mg/mL) and minimal bactericidal concentration (MBC: 0.11 mg/mL) of released THY were lower than the amount of free THY required, demonstrating the benefit of drug encapsulation for a more efficient bactericidal capacity due to the direct contact between mats and bacteria.</dc:description><dc:date>2020</dc:date><dc:source>http://zaguan.unizar.es/record/89694</dc:source><dc:doi>10.3390/nano10040616</dc:doi><dc:identifier>http://zaguan.unizar.es/record/89694</dc:identifier><dc:identifier>oai:zaguan.unizar.es:89694</dc:identifier><dc:relation>info:eu-repo/grantAgreement/EC/FP7/614715/EU/A Photo-triggered On-demand Drug Delivery System for Chronic Pain/NANOHEDONISM</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/CTQ2014-52384-R</dc:relation><dc:identifier.citation>Nanomaterials 10, 4 (2020), 616 [13 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>